FDA Import Refusal 112-4716369-4/1/1 — Celgene Cellular Therapeutics
The FDA refused shipment 112-4716369-4/1/1 from Celgene Cellular Therapeutics (United States) on Dec 21, 2004. The refused product falls under Drugs and Biologics — THALIDOMIDE (SEDATIVE). Cited charge: 179 This firm has 3 other import refusals on record.
Refusal details
- Date
- Dec 21, 2004
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 65VAC40 THALIDOMIDE (SEDATIVE)
- Charges
- 179